Xeris Pharmaceuticals
Latest round
- Series C
Last raised
- Mar 2018
Total raised
- $81M
Investors
- 9
About Xeris Pharmaceuticals
Xeris Pharmaceuticals, Inc.Founded in 2005, Xeris Pharmaceuticals, Inc. operates from Chicago, US, specializing in developing drug delivery systems.Xeris Pharmaceuticals specializes in the development and commercialization of innovative drug delivery systems, particularly in the fields of endocrinology and neurology. The company's core product offerings include unique formulations that enable patients to administer medications conveniently and effectively, particularly using their proprietary technology that simplifies the delivery of complex biologics. Their flagship products address critical health issues, including diabetes management through a steady supply of insulin, and they aim to enhance patient compliance by reducing the burden of multiple daily injections.S.02 mn. The company aims to expand its reach into European markets and enhance its product offerings that address chronic health conditions, capitalizing on its proprietary drug delivery technologies.
Who invested in Xeris Pharmaceuticals
9 investors across 3 rounds
See all investors in Xeris Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xeris Pharmaceuticals
Who invested in Xeris Pharmaceuticals?
Xeris Pharmaceuticals has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xeris Pharmaceuticals raised?
Xeris Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Xeris Pharmaceuticals last raise money?
Xeris Pharmaceuticals's most recent round on record is a Series C, in Mar 2018.
What does Xeris Pharmaceuticals do?
Xeris Pharmaceuticals is a pharmaceuticals company.
Where is Xeris Pharmaceuticals headquartered?
Xeris Pharmaceuticals is headquartered in Chicago, US.
Which VCs invest in companies like Xeris Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Xeris Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Xeris Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.